Utah Medical Products (NASDAQ:UTMD) Shares Pass Below 200-Day Moving Average – Time to Sell?

Utah Medical Products, Inc. (NASDAQ:UTMD)’s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $58.09 and traded as low as $55.01. Utah Medical Products shares last traded at $55.16, with a volume of 13,440 shares changing hands.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d+)” rating on shares of Utah Medical Products in a research report on Wednesday, October 8th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.

Utah Medical Products Stock Performance

The stock has a market capitalization of $176.73 million, a PE ratio of 15.58 and a beta of 0.33. The firm’s 50 day moving average is $59.06 and its two-hundred day moving average is $58.09.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Thursday, October 23rd. The medical instruments supplier reported $0.82 EPS for the quarter. Utah Medical Products had a net margin of 30.08% and a return on equity of 9.90%. The business had revenue of $9.81 million during the quarter.

Utah Medical Products Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, January 5th. Shareholders of record on Tuesday, December 16th will be issued a dividend of $0.31 per share. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.31. The ex-dividend date is Tuesday, December 16th. This represents a $1.24 annualized dividend and a yield of 2.2%. Utah Medical Products’s dividend payout ratio (DPR) is currently 35.03%.

Hedge Funds Weigh In On Utah Medical Products

Institutional investors and hedge funds have recently made changes to their positions in the stock. Envestnet Asset Management Inc. increased its stake in shares of Utah Medical Products by 37.7% during the first quarter. Envestnet Asset Management Inc. now owns 10,154 shares of the medical instruments supplier’s stock worth $569,000 after buying an additional 2,781 shares during the period. PNC Financial Services Group Inc. grew its holdings in Utah Medical Products by 156.9% during the 1st quarter. PNC Financial Services Group Inc. now owns 894 shares of the medical instruments supplier’s stock worth $50,000 after acquiring an additional 546 shares in the last quarter. Deutsche Bank AG increased its position in shares of Utah Medical Products by 321.9% in the 1st quarter. Deutsche Bank AG now owns 2,983 shares of the medical instruments supplier’s stock valued at $167,000 after purchasing an additional 2,276 shares during the last quarter. Bard Associates Inc. raised its holdings in shares of Utah Medical Products by 5.0% in the 1st quarter. Bard Associates Inc. now owns 21,032 shares of the medical instruments supplier’s stock valued at $1,185,000 after purchasing an additional 1,002 shares in the last quarter. Finally, Everett Harris & Co. CA lifted its position in shares of Utah Medical Products by 327.7% during the 1st quarter. Everett Harris & Co. CA now owns 17,116 shares of the medical instruments supplier’s stock worth $959,000 after purchasing an additional 13,114 shares during the last quarter. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.